hydroxyindoleacetic acid has been researched along with Heart Failure in 13 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
Excerpt | Relevance | Reference |
---|---|---|
"Depression is a proposed risk factor for heart failure based largely on epidemiological data; few experimental data addressing this hypothesis are available." | 5.40 | Effect of depression and sertraline treatment on cardiac function in female nonhuman primates. ( Groban, L; Kitzman, DW; Register, TC; Shively, CA, 2014) |
"05), indicative of increased central nervous system turnover of both catecholamines, occurred in cardiac failure and was quantitatively linked to the degree of activation of the cardiac sympathetic nervous outflow, as was the jugular overflow of the principal serotonin metabolite, 5-hydroxyindoleacetic acid." | 3.69 | Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients. ( Cox, HS; Esler, MD; Jennings, GL; Kaye, DM; Lambert, GW; Lefkovits, J; Turner, AG, 1995) |
"Depression is a proposed risk factor for heart failure based largely on epidemiological data; few experimental data addressing this hypothesis are available." | 1.40 | Effect of depression and sertraline treatment on cardiac function in female nonhuman primates. ( Groban, L; Kitzman, DW; Register, TC; Shively, CA, 2014) |
"We conclude that congestive heart failure may be associated with alterations in activity of bulbohypothalamic serotonergic nerves." | 1.26 | Alterations in brain serotonin during congestive heart failure in the cardiomyopathic Syrian hamster. ( Shum, A; Sole, MJ; VanLoon, GR, 1978) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (61.54) | 18.7374 |
1990's | 2 (15.38) | 18.2507 |
2000's | 1 (7.69) | 29.6817 |
2010's | 2 (15.38) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Groban, L | 1 |
Kitzman, DW | 1 |
Register, TC | 1 |
Shively, CA | 1 |
Nigmatullina, RR | 1 |
Kirillova, VV | 1 |
Jourjikiya, RK | 1 |
Mukhamedyarov, MA | 1 |
Kudrin, VS | 1 |
Klodt, PM | 1 |
Palotás, A | 1 |
Lu, KJ | 1 |
Rathi, V | 1 |
Calafiore, P | 1 |
Smith, G | 1 |
Srivastava, PM | 1 |
ANGELINO, PF | 1 |
CROLLE, G | 1 |
PELLEGRINI, A | 1 |
TARTARA, D | 1 |
PASSAGGIO, AM | 1 |
PAGANO, PG | 1 |
Lambert, GW | 2 |
Kaye, DM | 2 |
Cox, HS | 2 |
Vaz, M | 1 |
Turner, AG | 2 |
Jennings, GL | 2 |
Esler, MD | 2 |
Lefkovits, J | 1 |
Sole, MJ | 2 |
Shum, A | 2 |
Van Loon, GR | 1 |
Farndon, JR | 1 |
VanLoon, GR | 1 |
Smith, AG | 1 |
Greaves, MW | 1 |
Pik, A | 1 |
Levy, M | 1 |
Gilboa, Y | 1 |
Kojecký, Z | 1 |
Kodousek, R | 1 |
Mattingly, TW | 1 |
Andrus, EC | 1 |
Biörck, G | 1 |
Manion, WC | 1 |
13 other studies available for hydroxyindoleacetic acid and Heart Failure
Article | Year |
---|---|
Effect of depression and sertraline treatment on cardiac function in female nonhuman primates.
Topics: Analysis of Variance; Animals; Atherosclerosis; Body Weights and Measures; Comorbidity; Depression; | 2014 |
Disrupted serotonergic and sympathoadrenal systems in patients with chronic heart failure may serve as new therapeutic targets and novel biomarkers to assess severity, progression and response to treatment.
Topics: Adrenal Glands; Adrenergic beta-Antagonists; Adult; Biomarkers; Chronic Disease; Dihydroxyphenylalan | 2009 |
Multimodality imaging in an unusual case of palpitations and right heart failure.
Topics: Aged; Carcinoid Heart Disease; Fatal Outcome; Female; Fluorodeoxyglucose F18; Heart Failure; Heart N | 2011 |
[The determination of 5-hydroxy-indolacetic acid in acute coronary insufficiency].
Topics: Angina, Unstable; Heart Failure; Hydroxyindoleacetic Acid; Indoleacetic Acids | 1961 |
Regional 5-hydroxyindoleacetic acid production in humans.
Topics: Adolescent; Adult; Aged; Autonomic Nervous System; Diet; Heart Failure; Humans; Hydroxyindoleacetic | 1995 |
Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Cardiotonic Agents; Case-Control Studies; | 1995 |
Serotonin metabolism in the normal and failing hamster heart.
Topics: Animals; Cardiomyopathies; Cricetinae; Dihydroxytryptamines; Female; Heart Failure; Humans; Hydroxyd | 1979 |
The carcinoid syndrome: methods of treatment and recent experience with hepatic artery ligation and infusion.
Topics: Female; Fluorouracil; Heart Failure; Hepatic Artery; Humans; Hydroxyindoleacetic Acid; Ileum; Intest | 1977 |
Alterations in brain serotonin during congestive heart failure in the cardiomyopathic Syrian hamster.
Topics: Animals; Brain; Cardiomyopathies; Cricetinae; Heart Failure; Hydroxyindoleacetic Acid; Male; Mesocri | 1978 |
Blood prostaglandin activity associated with noradrenaline-provoked flush in the carcinoid syndrome.
Topics: Aged; Alkaline Phosphatase; Blister; Body Weight; Carcinoid Tumor; Chromatography, Thin Layer; Diarr | 1974 |
[Carcinoid syndrome of the small intestine].
Topics: Aged; Carcinoid Tumor; Heart Failure; Humans; Hydroxyindoleacetic Acid; Intestinal Neoplasms; Intest | 1969 |
[The enterochromaffin system and clinical consequences of hyperserotonism].
Topics: Biopsy; Chromaffin System; Cyanosis; Depression, Chemical; Female; Heart Failure; Humans; Hydroxyind | 1971 |
The functioning carcinoid tumor: a serendipity in diagnosis.
Topics: Adolescent; Adult; Ascites; Child; Female; Heart Failure; Humans; Hydroxyindoleacetic Acid; Ileum; I | 1966 |